March 23, 2022 — MedWatch, The FDA Safety Information and Adverse Event Reporting Program, announced today that Pfizer is recalling Accuretic (quinapril hydrochloride/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone (quinapril HCL and hydrochlorothiazide and quinapril HCl/hydrochlorothia

March 22, 2022 – The dominant form of heart failure worldwide appears to be caused by a strong, bidirectional interaction between the body’s response to metabolic stress and the immune system, according to a review article written by UT Southwestern researchers and colleagues.

March 22, 2022 – A retrospective evaluation of 600 fenestrated-branched endovascular aortic repairs for the treatment of complex aneurysms revealed that fewer than one in five patients experienced an intraoperative adverse event (IAE).
 

March 22, 2022 — A small study has shown that SARS-CoV-2 vaccination in patients who had an inflamed heart muscle in the past is not associated with a recurrence of the condition or other serious side effects.

March 22, 2022 – A Scripps Research team developed a smartphone app that can calculate users’ genetic risk for coronary artery disease (CAD)—and found that users at high risk sought out appropriate medication after using the app.

March 22, 2022 –  Women are less likely to receive lifesaving treatment for cardiogenic shock than men, according to research presented today at ESC Acute CardioVascular Care 2022, a scientific congress of the European Society of Cardiology (ESC).1

March 22, 2022 – Just 76% of heart attack patients with dyspnoea or fatigue as their main symptom are alive at one year compared to 94% of those with chest pain as the predominant feature.

March 22, 2022 – Medtronic, a global leader in healthcare technology, has announced leadership transitions for three of its Operating Units – Diabetes, Surgical Robotics, and Cardiac Rhythm Management – bringing in

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now